Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

U.S. health regulators on Monday approved a first-of-its-kind blood test for colon cancer, offering a new way of screening for a leading cause of cancer deaths. Palo Alto-based test manufacturer ...

Guardant Health is breaking barriers and hoping to get more people screened through the “Shield” test. In 2024, over 53,000 ...

Colon cancer is the most commonly diagnosed cancer and third leading cause of cancer deaths. It is also one of the most preventable types of cancer when it is detected early. Colon cancer screening ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing kit in the mail without ordering it yourself: your doctor or health care ...

Time for a rear-ality check. Colorectal cancer rates have been rising among adults younger than 50 since the 1990s, a troubling trend that has perplexed scientists. Because of the increase in cases, ...

Studies using the three-card, take-home method of FOBT screening repeated over a number of years have demonstrated mortality reductions of up to 33%. Conversely, there are no large studies documenting ...

NEW YORK (Reuters Health) - Screening tumors from all colon cancer patients could be a cost-effective way of spotting families at high genetic risk of the disease, a study published Monday suggests.